Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Evaluation of SARS-CoV-2 Vaccines in Patients With CLL/SLL

NCT04852822 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT04852822
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04852822 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Evaluation of SARS-CoV-2 Vaccines in Patients With CLL/SLL
Lead sponsor
University of Washington
Phase
Observational
Overall status
Terminated
Start date
March 18, 2021
Completion date
July 1, 2024
Enrollment
350 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lymphocytic leukemia, small lymphocytic lymphoma